Cost-effectiveness Analysis of CYP2D6*10 Pharmacogenetic Testing to Guide the Adjuvant Endocrine Therapy for Postmenopausal Women with Estrogen Receptor Positive Early Breast Cancer in China

Xiaoxia Wei; Hong Sun; Jie Zhuang; Xiuhua Weng; Bin Zheng; Qiwang Lin; Guifeng Zhang; Jiaqin Cai

doi:10.1007/s40261-019-00842-0

Cost-effectiveness Analysis of CYP2D6*10 Pharmacogenetic Testing to Guide the Adjuvant Endocrine Therapy for Postmenopausal Women with Estrogen Receptor Positive Early Breast Cancer in China

Clinical Drug Investigation ◽

10.1007/s40261-019-00842-0 ◽

2019 ◽

Vol 40 (1) ◽

pp. 25-32 ◽

Cited By ~ 2

Author(s):

Xiaoxia Wei ◽

Hong Sun ◽

Jie Zhuang ◽

Xiuhua Weng ◽

Bin Zheng ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cost Effectiveness ◽

Postmenopausal Women ◽

Endocrine Therapy ◽

Early Breast Cancer ◽

Cost Effectiveness Analysis ◽

Pharmacogenetic Testing ◽

Effectiveness Analysis ◽

Estrogen Receptor Positive

Download Full-text

Cost-Effectiveness Analysis of Fulvestrant 500 mg in Endocrine Therapy-Naïve Postmenopausal Women with Hormone Receptor-Positive Advanced Breast Cancer in the UK

PharmacoEconomics - Open ◽

10.1007/s41669-019-0134-3 ◽

2019 ◽

Vol 3 (4) ◽

pp. 559-570 ◽

Cited By ~ 2

Author(s):

Claire Telford ◽

Evelina Bertranou ◽

Samuel Large ◽

Hilary Phelps ◽

Mattias Ekman ◽

...

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Advanced Breast Cancer ◽

Postmenopausal Women ◽

Endocrine Therapy ◽

Hormone Receptor ◽

Cost Effectiveness Analysis ◽

Hormone Receptor Positive ◽

Effectiveness Analysis ◽

The Uk

Download Full-text

PCN32 COST-EFFECTIVENESS ANALYSIS OF LETROZOLE VERSUS TAMOXIFEN AS INITIAL ADJUVANT THERAPY IN HORMONE-RECEPTOR POSITIVE POSTMENOPAUSAL WOMEN WITH EARLY BREAST CANCER IN THE UK

Value in Health ◽

10.1016/s1098-3015(10)67270-1 ◽

2005 ◽

Vol 8 (6) ◽

pp. A43

Author(s):

J Karnon ◽

TE Delea ◽

NL Papo ◽

V Barghout ◽

SK Thomas ◽

...

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Adjuvant Therapy ◽

Postmenopausal Women ◽

Early Breast Cancer ◽

Hormone Receptor ◽

Cost Effectiveness Analysis ◽

Hormone Receptor Positive ◽

Effectiveness Analysis ◽

The Uk

Download Full-text

PCN189 COST-EFFECTIVENESS ANALYSIS OF PALBOCICLIB PLUS FULVESTRANT VERSUS EVEROLIMUS PLUS EXEMESTAN IN THE TREATMENT OF ESTROGEN RECEPTOR-POSITIVE, HER2-NEGATIVE, ADVANCED BREAST CANCER IN IRAN

Value in Health ◽

10.1016/j.jval.2019.09.385 ◽

2019 ◽

Vol 22 ◽

pp. S472

Author(s):

S. Taheri ◽

Z. Karimi Majd ◽

S. Rezaei ◽

N. Yousefi ◽

F. Peiravian

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cost Effectiveness ◽

Advanced Breast Cancer ◽

Cost Effectiveness Analysis ◽

Advanced Breast ◽

Effectiveness Analysis ◽

Estrogen Receptor Positive

Download Full-text

PCN116 A SURVIVAL BASED COST-EFFECTIVENESS ANALYSIS OF 5 YEARS LETROZOLE VERSUS TAMOXIFEN AS ADJUVANT THERAPY IN POSTMENOPAUSAL WOMEN WITH EARLY BREAST CANCER: CANADIAN PERSPECTIVE

Value in Health ◽

10.1016/s1098-3015(10)74367-9 ◽

2009 ◽

Vol 12 (7) ◽

pp. A279

Author(s):

K El Ouagari ◽

S Kaura ◽

JD Karnon

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Adjuvant Therapy ◽

Postmenopausal Women ◽

Early Breast Cancer ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Canadian Perspective

Download Full-text

P181 Cost-effectiveness analysis of letrozole vs. tamoxifen as initial adjuvant therapy in hormone-receptor positive postmenopausal women with early breast cancer: the Belgian perspective

The Breast ◽

10.1016/s0960-9776(07)70241-2 ◽

2007 ◽

Vol 16 ◽

pp. S64-S65

Author(s):

J. Karnon ◽

M. Berli`ere ◽

H. Depypere ◽

L. Dirix ◽

G. Jerusalem ◽

...

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Adjuvant Therapy ◽

Postmenopausal Women ◽

Early Breast Cancer ◽

Hormone Receptor ◽

Cost Effectiveness Analysis ◽

Hormone Receptor Positive ◽

Effectiveness Analysis

Download Full-text

A cost-effectiveness analysis of axillary node dissection in postmenopausal women with estrogen receptor–positive breast cancer and clinically negative axillary nodes

Surgery ◽

10.1016/s0039-6060(99)70100-5 ◽

1999 ◽

Vol 126 (3) ◽

pp. 568-576 ◽

Cited By ~ 16

Author(s):

Richard K. Orr ◽

Nananda F. Col ◽

Karen M. Kuntz

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cost Effectiveness ◽

Postmenopausal Women ◽

Axillary Node ◽

Axillary Node Dissection ◽

Node Dissection ◽

Effectiveness Analysis ◽

Estrogen Receptor Positive ◽

Positive Breast Cancer

Download Full-text

PCN19 AUSTRALIAN COST-EFFECTIVENESS ANALYSIS OF ANASTROZOLEVSTAMOXIFEN IN POSTMENOPAUSAL WOMEN WITH EARLY BREAST CANCER BASED ON THE 5-YEAR COMPLETED TREATMENT ANALYSIS OF THE ATAC TRIAL

Value in Health ◽

10.1016/s1098-3015(10)67257-9 ◽

2005 ◽

Vol 8 (6) ◽

pp. A39 ◽

Cited By ~ 1

Author(s):

A Benedict ◽

D Theodoratou ◽

A Maclean ◽

S Norris ◽

S Campbell ◽

...

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Postmenopausal Women ◽

Early Breast Cancer ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Treatment Analysis

Download Full-text

58P Cost-effectiveness analysis of trastuzumab emtansine versus trastuzumab for Chinese patients with residual invasive HER2-positive early breast cancer

Annals of Oncology ◽

10.1016/j.annonc.2021.03.072 ◽

2021 ◽

Vol 32 ◽

pp. S45

Author(s):

X. Guan ◽

H-C. Li ◽

Q-J. Chen ◽

B. Hua ◽

J-J. Li ◽

...

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Early Breast Cancer ◽

Cost Effectiveness Analysis ◽

Chinese Patients ◽

Trastuzumab Emtansine ◽

Her2 Positive ◽

Effectiveness Analysis

Download Full-text

Cost-effectiveness analysis of trastuzumab for early breast cancer in Brazil

Expert Review of Pharmacoeconomics & Outcomes Research ◽

10.1080/14737167.2021.1909478 ◽

2021 ◽

pp. 1-10

Author(s):

Carlos Henrique Botelho ◽

Maria Del Pilar Estevez-Diz ◽

Alessandro Gonçalves Campolina

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Early Breast Cancer ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis

Download Full-text

The clinical usefulness of the CTS5 in the prediction of late distant recurrence in postmenopausal women with estrogen receptor-positive early breast cancer

Breast Cancer ◽

10.1007/s12282-020-01130-y ◽

2020 ◽

Author(s):

Wakako Tajiri ◽

Hideki Ijichi ◽

Katsumi Takizawa ◽

Yumiko Koi ◽

Takanobu Masuda ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Postmenopausal Women ◽

Early Breast Cancer ◽

Distant Recurrence ◽

Clinical Usefulness ◽

Estrogen Receptor Positive

Download Full-text